Indomethacin for preterm labor: fetal toxicity in a dizygotic twin gestation

Obstet Gynecol. 1991 Nov;78(5 Pt 2):911-3.

Abstract

Indomethacin was given for the treatment of preterm labor in a twin pregnancy at a dosage of 200 mg/day for 7 days beginning at 34 weeks and 5 days' gestation. During treatment, one twin developed closure of the ductus arteriosus, tricuspid regurgitation, right ventricular dysfunction, and pericardial effusion. Severe oligohydramnios in both amniotic sacs appeared as well. All findings resolved within 7 days of discontinuation of the medication. The infants, delivered vaginally at 37 weeks' gestation, were alive and well at a 2-month follow-up visit. We believe that all fetuses of mothers treated with indomethacin should be closely monitored for early evidence of decreased amniotic fluid volume and constriction of the ductus arteriosus.

Publication types

  • Case Reports

MeSH terms

  • Abnormalities, Drug-Induced / diagnostic imaging
  • Abnormalities, Drug-Induced / etiology*
  • Abnormalities, Drug-Induced / pathology
  • Adult
  • Diseases in Twins / etiology*
  • Drug Monitoring
  • Ductus Arteriosus / abnormalities*
  • Ductus Arteriosus / pathology
  • Female
  • Fetal Diseases / chemically induced*
  • Fetal Diseases / diagnostic imaging
  • Humans
  • Indomethacin / adverse effects*
  • Obstetric Labor, Premature / drug therapy*
  • Obstetric Labor, Premature / prevention & control
  • Oligohydramnios / chemically induced*
  • Oligohydramnios / diagnostic imaging
  • Pericardial Effusion / chemically induced*
  • Pericardial Effusion / diagnostic imaging
  • Pericardial Effusion / pathology
  • Pregnancy
  • Tricuspid Valve Insufficiency / chemically induced*
  • Tricuspid Valve Insufficiency / diagnostic imaging
  • Tricuspid Valve Insufficiency / pathology
  • Ultrasonography

Substances

  • Indomethacin